| [1] | ZOU X,ZHANG M,SUN Y,et al.Inhibitory effects of 3-bromopyruvate in human nasopharyngeal carcinoma cells[J].Oncol Rep,2015,34(4):1895. |
| [2] | CARDACI S,DESIDERI E,CIRIOLO MR.Targeting aerobic glycolysis:3-bromopyruvate as a promising anticancer drug[J].J Bioenerg Biomembr,2012,44(1):17. |
| [3] | YU SJ,YOON JH,YANG JI,et al.Enhancement of hexokinase Ⅱ inhibitor-induced apoptosis in hepatocellular carcinoma cells via augmenting ER stress and anti-angiogenesis by protein disulfide isomerase inhibition[J].J Bioenerg Biomembr,2012,44(1):101. |
| [4] | LIU XH,ZHENG XF,WANG YL.Inhibitive effect of 3-bromopyruvic acid on human breast cancer MCF-7 cells involves cell cycle arrest and apoptotic induction[J].Chin Med J(Engl),2009,122(14):1681. |
| [5] | CHEN Z,ZHANG H,LU W,et al.Role of mitochondria-associated hexokinase Ⅱ in cancer cell death induced by 3-bromopyruvate[J].Biochim Biophys Acta,2009,1787(5):553. |
| [6] | PAN JG,MAK TW.Metabolic targeting as an anticancer strategy:dawn of a new era?[J].Sci S Stke,2007(381):pe14. |
| [7] | SCATENA R,BOTTONI P,PONTOGLIO A,et al.Glycolytic enzyme inhibitors in cancer treatment[J].Expert Opin Investig Drugs,2008,17(10):1533. |
| [8] | SHOSHAN MC.3-Bromopyruvate:targets and outcomes[J].J Bioenerg Biomembr,2012,44(1):7. |
| [9] | MOHANA-KUMARAN N,HILL DS,ALLEN JD,et al.Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy[J].Pigment Cell Melanoma Res,2014(27):525. |
| [10] | GREEN DR.Apoptotic pathways:ten minutes to dead[J].Cell,2005,121(5):671. |